Vigilant Capital Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$22K Sell
317
-1,974
-86% -$140K ﹤0.01% 346
2023
Q1
$170K Buy
2,291
+264
+13% +$22.1K 0.01% 155
2022
Q4
$189K Sell
2,027
-96
-5% -$9.26K 0.02% 149
2022
Q3
$202K Buy
2,123
+332
+19% +$32.9K 0.02% 147
2022
Q2
$166K Sell
1,791
-148
-8% -$14.4K 0.01% 165
2022
Q1
$196K Sell
1,939
-3,044
-61% -$320K 0.02% 173
2021
Q4
$514K Buy
4,983
+374
+8% +$34.6K 0.04% 111
2021
Q3
$391K Buy
4,609
+701
+18% +$58.7K 0.03% 105
2021
Q2
$326K Hold
3,908
0.03% 120
2021
Q1
$294K Sell
3,908
-60
-2% -$4.37K 0.03% 115
2020
Q4
$271K Buy
+3,968
New +$258K 0.03% 112
2019
Q1
Sell
-1,079
Closed -$71K 421
2018
Q4
$71K Buy
+1,079
New +$80.5K 0.01% 217
2018
Q2
Sell
-347
Closed -$22K 471
2018
Q1
$22K Sell
347
-55,991
-99% -$4.02M ﹤0.01% 298
2017
Q4
$4.08M Sell
56,338
-77,086
-58% -$5.6M 0.54% 54
2017
Q3
$10.8M Sell
133,424
-710
-0.5% -$56.2K 1.62% 27
2017
Q2
$10.8M Buy
134,134
+848
+0.6% +$67K 1.76% 17
2017
Q1
$10.5M Buy
133,286
+1,614
+1% +$129K 1.82% 15
2016
Q4
$10.4M Sell
131,672
-1,112
-0.8% -$90K 1.83% 14
2016
Q3
$11.8M Buy
132,784
+3,342
+3% +$315K 2.1% 12
2016
Q2
$12.4M Buy
129,442
+1,285
+1% +$128K 2.37% 8
2016
Q1
$13.3M Sell
128,157
-6,220
-5% -$605K 2.66% 6
2015
Q4
$13.1M Sell
134,377
-2,170
-2% -$213K 2.66% 6
2015
Q3
$13.2M Buy
136,547
+541
+0.4% +$56.9K 2.63% 7
2015
Q2
$14.3M Buy
136,006
+960
+0.7% +$98.1K 2.58% 7
2015
Q1
$13.9M Buy
135,046
+355
+0.3% +$35.9K 2.63% 6
2014
Q4
$13M Sell
134,691
-2,302
-2% -$203K 2.56% 5
2014
Q3
$10.9M Buy
136,993
+4,625
+3% +$365K 2.36% 11
2014
Q2
$9.98M Buy
132,368
+5,420
+4% +$410K 2.21% 14
2014
Q1
$9.5M Buy
126,948
+2,170
+2% +$153K 2.24% 12
2013
Q4
$8.93M Buy
124,778
+9,910
+9% +$637K 2.18% 13
2013
Q3
$6.52M Buy
114,868
+1,760
+2% +$105K 1.84% 20
2013
Q2
$6.47M Buy
+113,108
New +$6.55M 1.93% 18

Other funds holding CVS

Vigilant Capital Management's CVS Position: Q2 2023 in Review

Vigilant Capital Management reduced its CVS Health (CVS) stake by 86% in Q2 2023, selling an estimated $140K and leaving 317 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #346.

Vigilant Capital Management first reported a position in CVS in Q2 2013 and has held it in 32 quarters since. The position peaked at $14.3M in Q2 2015. 2,203 funds tracked by Wall St. Rank hold CVS as of Q2 2023.

  • Vigilant Capital Management held 317 shares of CVS Health worth $22K as of Q2 2023.
  • Vigilant Capital Management sold 1,974 CVS Health shares in Q2 2023, an estimated $140K.
  • CVS Health made up ﹤0.01% of Vigilant Capital Management's portfolio in Q2 2023, its #346 holding.
  • Vigilant Capital Management first reported a position in CVS Health in Q2 2013 and has held it in 32 quarters since.
  • Vigilant Capital Management's CVS Health position peaked at $14.3M in Q2 2015.
  • 2,203 funds tracked by Wall St. Rank held CVS Health as of Q2 2023.

Based on Vigilant Capital Management's 13F filing for Q2 2023, filed 8 Aug 2023.